Skip to main content
Top
Published in: European Journal of Nutrition 8/2014

01-12-2014 | Original Contribution

Inhibition of angiotensin-converting enzyme by aqueous extract of tomato

Authors: Dipankar Biswas, Md. Main Uddin, Lili L. Dizdarevic, Aud Jørgensen, Asim K. Duttaroy

Published in: European Journal of Nutrition | Issue 8/2014

Login to get access

Abstract

Purpose

To investigate the presence of anti-angiotensin converting enzyme (ACE) factors in aqueous extract of tomato.

Methods

The bio-guided fractionation of the aqueous extract of tomato produced a sugar-free, heat-stable fraction with molecular mass <1,000 Da from tomatoes. The sugar-free tomato extract (TE) was tested for its anti-ACE activity using human plasma and rabbit lung pure ACE. In addition, its effect on human platelet aggregation induced by ADP, collagen or arachidonic acid was determined. The mechanism of platelet inhibitory action of TE was investigated by measuring platelet factor 4 (PF4) release and cAMP synthesis by platelets.

Results

Typically, 100 g tomatoes produced 72.2 ± 4.7 mg of TE. This extract inhibited both platelet aggregation and plasma ACE activity in a dose-dependent manner. It inhibited platelet aggregation in response to ADP, collagen or arachidonic acid, and inhibitory action was mediated in part by reducing platelet PF4 release and by stimulating cAMP synthesis. The IC50 value of TE for ADP-induced platelet aggregation was 0.4 ± 0.02 mg/ml, whereas the IC50 value for ACE enzyme inhibition was 1.40 ± 0.04 mg/ml. Both the TE and commercially available sugar-free TE, Fruitflow®-2 had similar amount of catechin, and also had equal inhibitory potencies against platelet aggregation and plasma ACE activity.

Conclusion

Together these data indicate that aqueous extract of tomatoes contain anti-ACE factors in addition to previously described anti-platelet factors.
Literature
2.
go back to reference El-Atat F, McFarlane SI, Sowers JR (2004) Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep 6(3):215–223CrossRef El-Atat F, McFarlane SI, Sowers JR (2004) Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep 6(3):215–223CrossRef
3.
go back to reference Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665. doi:10.1136/bmj.b1665 CrossRef Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665. doi:10.​1136/​bmj.​b1665 CrossRef
4.
go back to reference Palomo I, Fuentes E, Padro T, Badimon L (2012) Platelets and atherogenesis: platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med 3(4):577–584. doi:10.3892/etm.2012.477 Palomo I, Fuentes E, Padro T, Badimon L (2012) Platelets and atherogenesis: platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med 3(4):577–584. doi:10.​3892/​etm.​2012.​477
6.
go back to reference Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ (2005) Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med 2(5):e133. doi:10.1371/journal.pmed.0020133 CrossRef Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ (2005) Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med 2(5):e133. doi:10.​1371/​journal.​pmed.​0020133 CrossRef
7.
go back to reference Griendling KK, Tsuda T, Berk BC, Alexander RW (1989) Angiotensin II stimulation of vascular smooth muscle cells. Secondary signalling mechanisms. Am J Hypertens 2(8):659–665CrossRef Griendling KK, Tsuda T, Berk BC, Alexander RW (1989) Angiotensin II stimulation of vascular smooth muscle cells. Secondary signalling mechanisms. Am J Hypertens 2(8):659–665CrossRef
8.
go back to reference Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA (2004) Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287(4):R943–R949. doi:10.1152/ajpregu.00265.2004 CrossRef Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA (2004) Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287(4):R943–R949. doi:10.​1152/​ajpregu.​00265.​2004 CrossRef
9.
go back to reference Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH (1991) Association of the renin–sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324(16):1098–1104. doi:10.1056/NEJM199104183241605 CrossRef Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH (1991) Association of the renin–sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324(16):1098–1104. doi:10.​1056/​NEJM199104183241​605 CrossRef
10.
go back to reference Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327(10):669–677. doi:10.1056/NEJM199209033271001 CrossRef Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327(10):669–677. doi:10.​1056/​NEJM199209033271​001 CrossRef
11.
go back to reference Schiffrin EL (2002) Vascular and cardiac benefits of angiotensin receptor blockers. Am J Med 113(5):409–418CrossRef Schiffrin EL (2002) Vascular and cardiac benefits of angiotensin receptor blockers. Am J Med 113(5):409–418CrossRef
12.
go back to reference Dzau VJ (1988) Circulating versus local renin–angiotensin system in cardiovascular homeostasis. Circulation 77(6 Pt 2):I4–13 Dzau VJ (1988) Circulating versus local renin–angiotensin system in cardiovascular homeostasis. Circulation 77(6 Pt 2):I4–13
13.
go back to reference Keidar S, Kaplan M, Shapira C, Brook JG, Aviram M (1994) Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 107(1):71–84CrossRef Keidar S, Kaplan M, Shapira C, Brook JG, Aviram M (1994) Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 107(1):71–84CrossRef
14.
go back to reference Kowala MC, Grove RI, Aberg G (1994) Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis 108(1):61–72CrossRef Kowala MC, Grove RI, Aberg G (1994) Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis 108(1):61–72CrossRef
15.
go back to reference Chobanian AV, Haudenschild CC, Nickerson C, Drago R (1990) Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15(3):327–331CrossRef Chobanian AV, Haudenschild CC, Nickerson C, Drago R (1990) Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15(3):327–331CrossRef
16.
17.
go back to reference Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER 3rd, Lin PH, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, Bales CW, Proschan MA (2001) Effects on blood lipids of a blood pressure-lowering diet: the dietary approaches to stop hypertension (DASH) trial. Am J Clin Nutr 74(1):80–89 Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER 3rd, Lin PH, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, Bales CW, Proschan MA (2001) Effects on blood lipids of a blood pressure-lowering diet: the dietary approaches to stop hypertension (DASH) trial. Am J Clin Nutr 74(1):80–89
21.
go back to reference Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG (2003) Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 555(3):597–600CrossRef Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG (2003) Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 555(3):597–600CrossRef
23.
go back to reference Engelhard YN, Gazer B, Paran E (2006) Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 151(1):100. doi:10.1016/j.ahj.2005.05.008 CrossRef Engelhard YN, Gazer B, Paran E (2006) Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 151(1):100. doi:10.​1016/​j.​ahj.​2005.​05.​008 CrossRef
25.
go back to reference O’Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK (2006) Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr 84(3):570–579 O’Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK (2006) Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr 84(3):570–579
26.
go back to reference Shidfar F, Froghifar N, Vafa M, Rajab A, Hosseini S, Shidfar S, Gohari M (2011) The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients. Int J Food Sci Nutr 62(3):289–294. doi:10.3109/09637486.2010.529072 CrossRef Shidfar F, Froghifar N, Vafa M, Rajab A, Hosseini S, Shidfar S, Gohari M (2011) The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients. Int J Food Sci Nutr 62(3):289–294. doi:10.​3109/​09637486.​2010.​529072 CrossRef
27.
go back to reference O’Kennedy N, Crosbie L, Whelan S, Luther V, Horgan G, Broom JI, Webb DJ, Duttaroy AK (2006) Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr 84(3):561–569 O’Kennedy N, Crosbie L, Whelan S, Luther V, Horgan G, Broom JI, Webb DJ, Duttaroy AK (2006) Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr 84(3):561–569
28.
go back to reference Yamamoto J, Taka T, Yamada K, Ijiri Y, Murakami M, Hirata Y, Naemura A, Hashimoto M, Yamashita T, Oiwa K, Seki J, Suganuma H, Inakuma T, Yoshida T (2003) Tomatoes have natural anti-thrombotic effects. Br J Nutr 90(6):1031–1038CrossRef Yamamoto J, Taka T, Yamada K, Ijiri Y, Murakami M, Hirata Y, Naemura A, Hashimoto M, Yamashita T, Oiwa K, Seki J, Suganuma H, Inakuma T, Yoshida T (2003) Tomatoes have natural anti-thrombotic effects. Br J Nutr 90(6):1031–1038CrossRef
30.
go back to reference Singleton VL, Orthofer R, Lamuela-Raventos RM (1999) Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteu reagent. Oxid Antioxid 299:152–178CrossRef Singleton VL, Orthofer R, Lamuela-Raventos RM (1999) Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteu reagent. Oxid Antioxid 299:152–178CrossRef
31.
go back to reference Dizdarevic LL, Biswas D, Uddin MM, Jorgenesen A, Falch E, Bastani NE, Duttaroy AK (2013) Inhibitory effects of kiwifruit extract on human platelet aggregation and plasma angiotensin-converting enzyme activity. Platelets. doi:10.3109/09537104.2013.852658 Dizdarevic LL, Biswas D, Uddin MM, Jorgenesen A, Falch E, Bastani NE, Duttaroy AK (2013) Inhibitory effects of kiwifruit extract on human platelet aggregation and plasma angiotensin-converting enzyme activity. Platelets. doi:10.​3109/​09537104.​2013.​852658
32.
go back to reference Dutta-Roy AK, Gordon MJ, Kelly C, Hunter K, Crosbie L, Knight-Carpentar T, Williams BC (1999) Inhibitory effect of Ginkgo biloba extract on human platelet aggregation. Platelets 10(5):298–305. doi:10.1080/09537109975933 CrossRef Dutta-Roy AK, Gordon MJ, Kelly C, Hunter K, Crosbie L, Knight-Carpentar T, Williams BC (1999) Inhibitory effect of Ginkgo biloba extract on human platelet aggregation. Platelets 10(5):298–305. doi:10.​1080/​09537109975933 CrossRef
33.
go back to reference Hua J, Suguro S, Iwabuchi K, Tsutsumi-Ishii Y, Sakamoto K, Nagaoka I (2004) Glucosamine, a naturally occurring amino monosaccharide, suppresses the ADP-mediated platelet activation in humans. Inflamm Res Off J Eur Histamine Res Soc [et al] 53(12):680–688. doi:10.1007/s00011-004-1312-y Hua J, Suguro S, Iwabuchi K, Tsutsumi-Ishii Y, Sakamoto K, Nagaoka I (2004) Glucosamine, a naturally occurring amino monosaccharide, suppresses the ADP-mediated platelet activation in humans. Inflamm Res Off J Eur Histamine Res Soc [et al] 53(12):680–688. doi:10.​1007/​s00011-004-1312-y
34.
go back to reference Loizzo MR, Said A, Tundis R, Rashed K, Statti GA, Hufner A, Menichini F (2007) Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother Res: PTR 21(1):32–36. doi:10.1002/ptr.2008 CrossRef Loizzo MR, Said A, Tundis R, Rashed K, Statti GA, Hufner A, Menichini F (2007) Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother Res: PTR 21(1):32–36. doi:10.​1002/​ptr.​2008 CrossRef
35.
go back to reference Nyman U, Joshi P, Madsen LB, Pedersen TB, Pinstrup M, Rajasekharan S, George V, Pushpangadan P (1998) Ethnomedical information and in vitro screening for angiotensin-converting enzyme inhibition of plants utilized as traditional medicines in Gujarat, Rajasthan and Kerala (India). J Ethnopharmacol 60(3):247–263CrossRef Nyman U, Joshi P, Madsen LB, Pedersen TB, Pinstrup M, Rajasekharan S, George V, Pushpangadan P (1998) Ethnomedical information and in vitro screening for angiotensin-converting enzyme inhibition of plants utilized as traditional medicines in Gujarat, Rajasthan and Kerala (India). J Ethnopharmacol 60(3):247–263CrossRef
36.
go back to reference Park PJ, Je JY, Kim SK (2003) Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans. J Agric Food Chem 51(17):4930–4934. doi:10.1021/jf0340557 CrossRef Park PJ, Je JY, Kim SK (2003) Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans. J Agric Food Chem 51(17):4930–4934. doi:10.​1021/​jf0340557 CrossRef
37.
go back to reference Guerrero L, Castillo J, Quinones M, Garcia-Vallve S, Arola L, Pujadas G, Muguerza B (2012) Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLoS ONE 7(11):e49493. doi:10.1371/journal.pone.0049493 CrossRef Guerrero L, Castillo J, Quinones M, Garcia-Vallve S, Arola L, Pujadas G, Muguerza B (2012) Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLoS ONE 7(11):e49493. doi:10.​1371/​journal.​pone.​0049493 CrossRef
38.
go back to reference Corradini E, Foglia P, Giansanti P, Gubbiotti R, Samperi R, Lagana A (2011) Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants. Nat Prod Res 25(5):469–495. doi:10.1080/14786419.2010.482054 CrossRef Corradini E, Foglia P, Giansanti P, Gubbiotti R, Samperi R, Lagana A (2011) Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants. Nat Prod Res 25(5):469–495. doi:10.​1080/​14786419.​2010.​482054 CrossRef
Metadata
Title
Inhibition of angiotensin-converting enzyme by aqueous extract of tomato
Authors
Dipankar Biswas
Md. Main Uddin
Lili L. Dizdarevic
Aud Jørgensen
Asim K. Duttaroy
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 8/2014
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-014-0676-1

Other articles of this Issue 8/2014

European Journal of Nutrition 8/2014 Go to the issue